Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cannabis Strategies Acquisition Corp. was a cannabis-focused special purpose acquisition corporation formed in Canada to acquire one or more businesses in the marijuana production, distribution, and related sectors. The company completed its initial public offering in December 2017 and was sponsored by Mercer Park CB, L.P. In May 2019, it completed its qualifying transaction, acquired a portfolio of U.S. cannabis assets, and changed its name to Ayr Strategies Inc., later Ayr Wellness Inc. As a standalone entity under the name Cannabis Strategies Acquisition, it no longer operates independently; the name is primarily relevant as the predecessor SPAC to Ayr.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cannabis Strategies Acquisition.